Semaglutide extended lifespan in older female mice, but that was not the only finding
A late-life experiment reveals how a widely used metabolic drug reshapes age-related physiology and molecular pathways, with effects…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Nearly one in 10 Britons use or want weight-loss medication
A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
New oral drug shows promise for chronic heart failure treatment
An early clinical study shows that a new oral drug is safe and well-tolerated in patients with chronic…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new…
Exercise remains essential alongside GLP-1 obesity treatments
As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in the Journal of the American…
GLP-1 medications show mixed effects on body contouring outcomes
For patients undergoing body contouring surgery to remove excess abdominal skin after massive weight loss, use of GLP-1 weight-loss medications may have mixed effects…
Study finds GLP-1 medicines cut fat while preserving muscle function
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while…
Combining healthy lifestyle and GLP-1 therapy reduces heart risks in diabetes
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
UCLA Health finds eco-friendly inhalers improve COPD outcomes
New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are…